Intarcia Therapeutics has a total of 662 patents globally, out of which 367 have been granted. Of these 662 patents, more than 51% patents are active. The United States of America is where Intarcia Therapeutics has filed the maximum number of patents, followed by Australia and Japan. Parallelly, United States of America seems to be the main focused R&D center and also is the origin country of Intarcia Therapeutics.
Intarcia Therapeutics was founded in 1995. Intarcia Therapeutics operates as a biopharmaceutical company. The Company develops and commercializes therapies to enhance treatment outcomes.
Read about some of the most popular patents of Intarcia Therapeutics which have been covered by us in this article and also you can find Intarcia Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Intarcia Therapeutics patent portfolio.
How many patents does the CEO of Intarcia Therapeutics have?
The CEO Kurt C. Graves has 20 patents.
How many patents does Intarcia Therapeutics have?
Intarcia Therapeutics has a total of 662 patents globally. These patents belong to 85 unique patent families. Out of 662 patents, 344 patents are active.
How Many Patents did Intarcia Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Intarcia Applications Filed | Intarcia Patents Granted |
| 2011 | 16 | 18 |
| 2012 | 21 | 28 |
| 2013 | 6 | 27 |
| 2014 | 11 | 7 |
| 2015 | 10 | 10 |
| 2016 | 75 | 12 |
| 2017 | 29 | 47 |
| 2018 | 31 | 26 |
| 2019 | 22 | 12 |
| 2020 | 9 | 16 |
| 2021 | 14 | 11 |
| 2022 | 2 | 6 |
How many Intarcia Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Intarcia Therapeutics File in Different Countries?
Countries in which Intarcia Therapeutics Filed Patents
| Country | Patents |
| United States Of America | 137 |
| Australia | 57 |
| Japan | 52 |
| Hong Kong (S.A.R.) | 47 |
| Europe | 43 |
| China | 42 |
| New Zealand | 36 |
| Israel | 35 |
| Canada | 31 |
| Korea (South) | 27 |
| Germany | 21 |
| India | 16 |
| Denmark | 13 |
| Mexico | 13 |
| Spain | 10 |
| Singapore | 9 |
| Russia | 9 |
| Austria | 8 |
| Portugal | 5 |
| Poland | 5 |
| Cyprus | 5 |
| Taiwan | 4 |
| Argentina | 4 |
| Slovenia | 3 |
| Brazil | 3 |
| Croatia | 2 |
| United Kingdom | 2 |
| Macao | 2 |
| Albania | 1 |
| Hungary | 1 |
| Czech Republic | 1 |
| Lithuania | 1 |
Where are Research Centers of Intarcia Therapeutics Patents Located?
10 Best Intarcia Therapeutics Patents
US6375978B1 is the most popular patent in the Intarcia Therapeutics portfolio. It has received 458 citations so far from companies like Atyr Pharma Inc, Abbvie Inc and Pfizer Inc.
Below is the list of 10 most cited patents of Intarcia Therapeutics:
| Publication Number | Citation Count |
| US6375978B1 | 458 |
| US6395292B2 | 337 |
| US6939556B2 | 205 |
| US6923800B2 | 199 |
| US6635268B2 | 199 |
| US7014636B2 | 159 |
| US6508808B1 | 158 |
| US6524305B1 | 157 |
| US6544252B1 | 148 |
| US7258869B1 | 132 |
What Percentage of Intarcia Therapeutics US Patent Applications were Granted?
Intarcia Therapeutics (Excluding its subsidiaries) has filed 177 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 97 have been granted leading to a grant rate of 69.7%.
Below are the key stats of Intarcia Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Intarcia Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Cooley Llp | 71 | 87.69% |
| Intarcia Therapeutics Inc | 37 | 4.55% |
| Lathrop Gpm Llp | 18 | 86.67% |
| Joseph F Shirtz | 5 | 0% |
| Robert G Mukai | 4 | 0% |
| Dechert Llp | 3 | 0.00% |
| Pauline Ann Clarke | 3 | 0% |
| Bakerhostetler | 2 | 0% |
| Dewipat Incorporated | 2 | 0% |
| Alza Corporation | 1 | 0% |
EXCLUSIVE INSIGHTS COMING SOON!